2nd Quarter - Report

ZIMMER BIOMET, INC. for ZIMMER BIOMET, INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$110,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 20, 2016 $110,000 Replaced
2nd Quarter - Amendment Jul 20, 2016 $120,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Energy and Commerce Committee's 21st Century Cures; Medicare payment (CCJR and proposed Medicare Inpatient Payment and Physician Payment Rules); FDA inspections; FY17 Ag Appropriations; MDUFA Reauthorization; FDA re-processing regulations

LobbyistCovered position, as disclosed
CHRISTOPHER A CERONE —
WHITNEY TULL —

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE

Trade (domestic/foreign) TRD

TPP

LobbyistCovered position, as disclosed
CHRISTOPHER A CERONE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR)

Taxation/Internal Revenue Code TAX

Corporate Tax Reform, MDET Repeal

LobbyistCovered position, as disclosed
CHRISTOPHER A CERONE —
WHITNEY TULL —

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.